Atlas Trials

Gastroesophageal Junction (GEJ) Adenocarcinoma

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gastroesophageal Junction (GEJ) Adenocarcinoma

RecordFirmDate
Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (NCT07689292)Tianjin Medical University Cancer Institute and Hospital2026-07-31
Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma (NCT07692334)West China Second University Hospital2026-07-20
Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma (NCT07699939)National Cancer Center, Japan2026-07-15
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma (NCT07529808)BigHat Biosciences, Inc.2026-07-01
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer (NCT07673887)Astellas Pharma Global Development, Inc.2026-06-30
Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma (NCT07507916)Fudan University2026-04-01
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors (NCT07284186)Plexium, Inc.2025-12-01
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 (NCT07218003)Rondo Therapeutics2025-11-17
An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma (NCT07018570)National Cancer Center Hospital East2025-07-24
The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors (NCT05964543)QureBio Ltd.2023-06-21
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer (NCT05365581)Astellas Pharma Global Development, Inc.2022-06-07

Track Gastroesophageal Junction (GEJ) Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.